Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation Journal Article


Authors: Funato, K.; Major, T.; Lewis, P. W.; Allis, C. D.; Tabar, V.
Article Title: Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Abstract: Over 70% of diffuse intrinsic pediatric gliomas, an aggressive brainstem tumor, harbor heterozygous mutations that create a K27M amino acid substitution (methionine replaces lysine 27) in the tail of histone H3.3. The role of the H3.3K27M mutation in tumorigenesis is not fully understood. Here, we use a human embryonic stem cell system to model this tumor. We show that H3.3K27M expression synergizes with p53 loss and PDGFRA activation in neural progenitor cells derived from human embryonic stem cells, resulting in neoplastic transformation. Genome-wide analyses indicate a resetting of the transformed precursors to a developmentally more primitive stem cell state, with evidence of major modifications of histone marks at several master regulator genes. Drug screening assays identified a compound targeting the protein menin as an inhibitor of tumor cell growth in vitro and in mice.
Keywords: mus
Journal Title: Science
Volume: 346
Issue: 6216
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2014-12-19
Start Page: 1529
End Page: 1533
Language: English
DOI: 10.1126/science.1253799
PROVIDER: scopus
PUBMED: 25525250
PMCID: PMC4995593
DOI/URL:
Notes: Export Date: 2 January 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Viviane S Tabar
    224 Tabar
  2. Tamara Major
    4 Major
  3. Kosuke Funato
    14 Funato